On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q2 2023 earnings per share (EPS) of -$0.54, up 11.48% year over year. Total Acasti Pharma earnings for the quarter were -$4.02 million. In the same quarter last year, Acasti Pharma's earnings per share (EPS) was -$0.61.
As of Q3 2023, Acasti Pharma's earnings has grown year over year. Acasti Pharma's earnings in the past year totalled -$41.93 million.
What is ACST's earnings date?
Acasti Pharma's earnings date is Invalid Date. Add ACST to your watchlist to be reminded of ACST's next earnings announcement.
What was ACST's revenue last quarter?
On Invalid Date, Acasti Pharma (NASDAQ: ACST) reported Q2 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Acasti Pharma's revenue was $0.00.
What was ACST's revenue growth in the past year?
As of Q3 2023, Acasti Pharma's revenue has grown null year over year. Acasti Pharma's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.